Utilizing exclusive, patented LipiSperse® technology means that resveratrol’s normally limited ability to dissolve in aqueous environments (such as the stomach), is enhanced and can disperse freely, increasing VeriSperse®’s bioavailability and therefore efficacy as it becomes more readily available.
VeriSperse® is a trademark of Pharmako Biotechnologies Pty Ltd.
VeriSperse® has an equilibrium established between the LipiSperse® on the powder surface and the solution. Repulsive forces between the particles prevent agglomeration or aggregation: allowing VeriSperse® to have proper particle dispersion. Proper dispersion offers advantages in absorption, dosage requirements, efficacy and final product quality.